Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;100(2):160-164.
doi: 10.1016/j.contraception.2019.04.006. Epub 2019 Apr 17.

Abortion providers' experiences and views on self-managed medication abortion: an exploratory study

Courtney A Kerestes  1 , Colleen K Stockdale  2 , M Bridget Zimmerman  3 , Abbey J Hardy-Fairbanks  2
Affiliations

Abortion providers' experiences and views on self-managed medication abortion: an exploratory study

Courtney A Kerestes et al. Contraception. 2019 Aug.

Abstract

Objective: Data on the practice of self-managed medication abortion are limited, in part because this practice takes place purposefully outside of established healthcare systems. Given this, we aimed to ascertain abortion providers' familiarity with self-managed medication abortion and associated complications, compare regional differences and evaluate provider attitudes.

Study design: We distributed an online survey to members of Society for Family Planning, Association of Reproductive Health Providers and the Abortion Care Network between July and September 2017 querying experiences with and opinions about self-managed abortion.

Results: Of 650 respondents, 359 (55.1%) were direct abortion providers. Two hundred and thirty of 335 providers (68.6%) had experience with women trying to interrupt pregnancies on their own, and of those, 153 (76.1%) had seen use of misoprostol and/or mifepristone, and 204 of 342 (59.6%) thought this practice increased in the past 5 years. One hundred and seventeen of 335 (34.9%), witnessed complications from self-managed abortion with misoprostol/mifepristone, most commonly incomplete abortion and less often hemorrhage, sepsis and uterine rupture. Half of providers, 171 of 321 (53.3%), think that the use of misoprostol/mifepristone for the self-management of abortion is safe.

Conclusion: Two thirds of respondents had experiences with women attempting to self-manage abortion, and about a third witnessed complications related to self-managed medication abortion. About half of respondents agreed that self-managed abortion is safe.

Implications: This study establishes that self-managed abortion is a practice which a majority of respondents have seen among their patients and, because of its prevalence, an area that warrants further research.

Keywords: Medical abortion; Misoprostol; Provider attitudes; Self-managed abortion; Telemedicine.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Number of participants reporting having seen each type of complication of a patient presenting after self-sourced medical abortion with mifepristone and/or misoprostol.
Figure 2.
Figure 2.
Opinions on safety, desirability, and alternatives to in-clinic medical abortion amongst all respondents.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Grossman D, Grindlay K. Safety of Medical Abortion Provided Through Telemedicine Compared With In Person. Obstetrics and gynecology. 2017;130:778–82. - PubMed
    1. Aiken ARA, Digol I, Trussell J, Gomperts R. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland. Bmj. 2017;357:j2011. - PMC - PubMed
    1. Nash E, Gold RB, Mohammed L, Ansari-Thomas Z, Cappello O. Policy Trends in the States, 2017. Policy Analysis Guttmacher Institute; 2018.
    1. Bearak JM, Burke KL, Jones RK. Disparities and change over time in distance women would need to travel to have an abortion in the USA: a spatial analysis. The Lancet Public Health.2:e493–e500. - PMC - PubMed
    1. Murtagh C, Wells E, Raymond EG, Coeytaux F, Winikoff B. Exploring the feasibility of obtaining mifepristone and misoprostol from the internet. Contraception. 2017. - PubMed

Publication types

MeSH terms